A study from New York University Langone Medical Center, published in JAMA Psychiatry in January 2021, revealed that people living with schizophrenia who contracted Covid-19 were 2.7 times more likely to die than those without psychiatric illness — a risk surpassed only by age itself. Drawing on nearly 7,400 cases across New York's first pandemic wave, researchers found no direct biological mechanism to explain the disparity, pointing instead toward something older and more troubling: a healthcare system that has long failed its most vulnerable. The virus did not single out schizophrenia — it
Schizophrenia linked to 2.7x higher Covid mortality risk, second only to age
Cobertura Relacionada
Hundreds of thousands of UK students received GCSE results showing overall grade improvements in 2025, with the gender g…
The Straits Times · Aug 20 Ebola spreads beyond Congo epicentre, overwhelming treatment capacityEbola cases in DRC are accelerating outside the initial Ituri epicenter, with North Kivu and Haut-Uélé provinces experie…
Science Daily · Aug 20 1,000+ genetic switches explain why women face higher autoimmune disease riskResearchers identified over 1,000 genetic switches that function differently in male and female immune cells, explaining…
News-Medical · Aug 20 Brain's Local Wiring May Buffer Cognitive Decline in Older AdultsUSC researchers found that white matter integrity helps protect cognitive function in older adults by compensating for g…
Sesgo y Encuadre
No hay datos de análisis detallado para esta lente. Intenta volver a ejecutar las lentes desde el panel de administración.
Impacto Geopolítico
Medical research finding on psychiatric comorbidity and COVID mortality has no direct geopolitical implications; this is a public health/epidemiological study.
Lente Económico
Schizophrenia identified as second-highest Covid-19 mortality risk factor after age (2.7x higher death risk), with significant implications for healthcare resource allocation and mental health service capacity.
Individuals with schizophrenia face substantially elevated healthcare costs, insurance premiums, and need for specialized Covid-19 treatment protocols. Households with affected members may experience increased out-of-pocket expenses and reduced workforce participation due to health complications.
Governments likely to prioritize schizophrenia patients in vaccination campaigns and Covid-19 treatment access; mental health services funding may increase; healthcare systems may require enhanced psychiatric-medical integration; insurance regulations may need adjustment for pre-existing psychiatric conditions; workplace accommodations and disability support programs may expand.